Company overview
Basic information
Company name
InMedica, UAB
Company code
300011170
VAT code
LT100000938119
Registered address
Vilnius, Juozo Balčikonio g. 3, LT-08247
Registration date
2004-03-18
Company age: 22 y. 6 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.inmedica.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
UAB InMedica
Company code: 300011170
Address: Vilnius, Juozo Balčikonio g. 3, LT-08247
VAT code: LT100000938119
Download a detailed company report
Make confident decisions with all the information about InMedica, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
InMedica, UAB (company code 300011170) is a private limited liability company registered in 2004 and currently operational. The company is based in Vilnius, at Juozo Balcikonio g. 3, Vilniaus m. sav., Vilniaus apskr. It operates in the non-financial sector controlled by foreign entities and is organised as a private company with private ownership, where foreign natural and legal persons hold more than 50% of the authorised capital. Governance is described as CEO only. Its activity is classified under EVRK code R.86.21.00, General medical practice activities.
The company is classified as large, with a share capital of EUR 1.37 million. Financially, InMedica recorded revenue of EUR 103.98 million in 2024, compared with EUR 85.74 million in 2023. Net profit for 2024 was EUR 3.26 million, after a net loss of EUR 233.5 thousand in 2023, and the 2024 profit margin was 3.1%. Total assets increased to EUR 140.07 million in 2024, while liabilities reached EUR 103.17 million. Staff numbers continued to rise, with an average of 3,726 employees so far in 2026, up from 3,156 in 2025. The average monthly wage was EUR 2,764.37 so far in 2026, compared with EUR 2,604.18 in 2025.
The company is classified as large, with a share capital of EUR 1.37 million. Financially, InMedica recorded revenue of EUR 103.98 million in 2024, compared with EUR 85.74 million in 2023. Net profit for 2024 was EUR 3.26 million, after a net loss of EUR 233.5 thousand in 2023, and the 2024 profit margin was 3.1%. Total assets increased to EUR 140.07 million in 2024, while liabilities reached EUR 103.17 million. Staff numbers continued to rise, with an average of 3,726 employees so far in 2026, up from 3,156 in 2025. The average monthly wage was EUR 2,764.37 so far in 2026, compared with EUR 2,604.18 in 2025.